The Ledger Review
HomeTagsBiopharma Strategy

Biopharma Strategy

1 article tagged with "biopharma strategy"

Beyond the Headline: Why Ovid''s $53.9M Warrant Exercise Signals a Strategic
Market Insights

Beyond the Headline: Why Ovid''s $53.9M Warrant Exercise Signals a Strategic

In April 2026, Ovid Therapeutics secured $53.9 million through warrant exercises,

Ovid Therapeuticswarrant exercisebiotech financing+4
Marcus Vanhoutte
Marcus Vanhoutte